Polakova, K. M., Žižková, H., Vajnerova, R., Suchankova, P., Benesova, A., Hornak, T., Klamova, H., Srbova, D., Salek, C., Faber, E., Papajik, T., Belohlavkova, P., Voglova, J., Zak, P., Stejskal, L., Cerna, O., Cmunt, E., Jeziskova, I., Jurcek, T., Mayer, J., Zackova, D. (2025). DNA-based MRD monitoring enhances risk stratification during TKI dose reduction in CML: Evidence from the clinical trial. Blood. https://doi.org/10.1182/blood-2025-78